James Gordon
Stock Analyst at J.P. Morgan
(3.16)
# 2,427
Out of 4,345 analysts
540
Total ratings
54.6%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by James Gordon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $156 → $72 | $50.82 | +40.95% | 5 | Mar 11, 2026 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Maintained: Buy | €67.00 → €70.00 | $51.15 | +36.85% | 10 | Dec 8, 2025 | |
| LON: GSK GSK plc | Maintained: Sell | 1,400p | $1,939.50 | -27.82% | 164 | Sep 18, 2025 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 46.00 → CHF 55.00 | $64.52 | -14.76% | 3 | Sep 16, 2025 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €730.00 | $702.93 | +3.85% | 26 | Aug 26, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,500p | $1,495.00 | +67.22% | 27 | Aug 8, 2025 | |
| ARGX argenx SE | Maintained: Buy | $775 → $830 | $821.37 | +1.05% | 16 | Aug 4, 2025 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 14,000p | $14,008.00 | -0.06% | 169 | Jul 29, 2025 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 120.00 → CHF 160.00 | $162.75 | -1.69% | 2 | Jul 25, 2025 | |
| LON: OXB Oxford Biomedica plc | Maintained: Hold | 490p → 400p | $623.00 | -35.79% | 7 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $10 | $8.05 | +27.95% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €9.50 → €12.00 | $9.69 | +23.86% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 1,700 → kr 1,500 | $1,716.00 | -12.59% | 15 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 190p | $136.60 | n/a | 13 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.20 → CHF 1.00 | $4.49 | n/a | 14 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €34.00 → €29.00 | $24.20 | n/a | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $32 | $27.70 | n/a | 8 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $15 | $16.15 | n/a | 11 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $47 | $82.25 | n/a | 3 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 55.00 → CHF 57.00 | $52.76 | n/a | 5 | Nov 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 400.00 | $330.90 | n/a | 1 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $39.20 | n/a | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 8,156p → 9,268p | $59.00 | n/a | 2 | Dec 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $51.58 | n/a | 2 | Aug 15, 2016 |
Zealand Pharma A/S
Mar 11, 2026
Maintained: Buy
Price Target: $156 → $72
Current: $50.82
Upside: +40.95%
Recordati Industria Chimica e Farmaceutica S.p.A.
Dec 8, 2025
Maintained: Buy
Price Target: €67.00 → €70.00
Current: $51.15
Upside: +36.85%
GSK plc
Sep 18, 2025
Maintained: Sell
Price Target: 1,400p
Current: $1,939.50
Upside: -27.82%
Sandoz Group AG
Sep 16, 2025
Maintained: Buy
Price Target: CHF 46.00 → CHF 55.00
Current: $64.52
Upside: -14.76%
argenx SE
Aug 26, 2025
Maintained: Buy
Price Target: €730.00
Current: $702.93
Upside: +3.85%
Hikma Pharmaceuticals PLC
Aug 8, 2025
Reiterated: Buy
Price Target: 2,500p
Current: $1,495.00
Upside: +67.22%
argenx SE
Aug 4, 2025
Maintained: Buy
Price Target: $775 → $830
Current: $821.37
Upside: +1.05%
AstraZeneca PLC
Jul 29, 2025
Maintained: Buy
Price Target: 14,000p
Current: $14,008.00
Upside: -0.06%
Galderma Group AG
Jul 25, 2025
Maintained: Buy
Price Target: CHF 120.00 → CHF 160.00
Current: $162.75
Upside: -1.69%
Oxford Biomedica plc
Jul 15, 2025
Maintained: Hold
Price Target: 490p → 400p
Current: $623.00
Upside: -35.79%
Jun 17, 2025
Maintained: Hold
Price Target: $12 → $10
Current: $8.05
Upside: +27.95%
Jun 17, 2025
Maintained: Hold
Price Target: €9.50 → €12.00
Current: $9.69
Upside: +23.86%
Jun 6, 2025
Maintained: Hold
Price Target: kr 1,700 → kr 1,500
Current: $1,716.00
Upside: -12.59%
Mar 5, 2025
Maintained: Buy
Price Target: 190p
Current: $136.60
Upside: n/a
Dec 3, 2024
Maintained: Hold
Price Target: CHF 1.20 → CHF 1.00
Current: $4.49
Upside: n/a
Oct 23, 2024
Maintained: Hold
Price Target: €34.00 → €29.00
Current: $24.20
Upside: n/a
Oct 22, 2024
Maintained: Hold
Price Target: $37 → $32
Current: $27.70
Upside: n/a
Oct 9, 2024
Maintained: Hold
Price Target: $13 → $15
Current: $16.15
Upside: n/a
May 8, 2024
Maintained: Buy
Price Target: $43 → $47
Current: $82.25
Upside: n/a
Nov 16, 2020
Maintained: Hold
Price Target: CHF 55.00 → CHF 57.00
Current: $52.76
Upside: n/a
May 14, 2020
Maintained: Buy
Price Target: CHF 400.00
Current: $330.90
Upside: n/a
Apr 2, 2020
Upgraded: Buy
Price Target: n/a
Current: $39.20
Upside: n/a
Dec 29, 2017
Maintained: Hold
Price Target: 8,156p → 9,268p
Current: $59.00
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $51.58
Upside: n/a